Literature DB >> 17697155

Links between arterial and venous disease.

P Prandoni1.   

Abstract

An increasing body of evidence suggests the likelihood of a link between arterial and venous disease. According to the results of recent studies, atherosclerosis and venous thromboembolism (VTE) share common risk factors, including age, obesity, diabetes mellitus and metabolic syndrome. Atherosclerosis has the potential to promote the development of thrombotic disorders in the venous system. Another scenario assumes that the two clinical conditions are simultaneously triggered by biological stimuli responsible for activating coagulation and inflammatory pathways in both the arterial and the venous system. Several recent studies have consistently shown that patients with VTE of unknown origin are at a higher risk of cardiovascular diseases, including atherosclerotic complications, than patients with secondary VTE and matched control individuals. Future studies are needed to clarify the nature of this association, to assess its extent and to evaluate its implications for clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17697155     DOI: 10.1111/j.1365-2796.2007.01815.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  22 in total

1.  Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay.

Authors:  Armando Tripodi; Adriana Branchi; Veena Chantarangkul; Marigrazia Clerici; Giuliana Merati; Andrea Artoni; Pier Mannuccio Mannucci
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

2.  Prolonged work- and computer-related seated immobility and risk of venous thromboembolism.

Authors:  Bridget Healy; Erik Levin; Kyle Perrin; Mark Weatherall; Richard Beasley
Journal:  J R Soc Med       Date:  2010-11       Impact factor: 5.344

3.  Angiotensin II-mediated microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Lidiana D Almeida-Paula; Joseph W Harding; D Neil Granger
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

4.  Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.

Authors:  Solveig Gretarsdottir; Annette F Baas; Gudmar Thorleifsson; Hilma Holm; Martin den Heijer; Jean-Paul P M de Vries; Steef E Kranendonk; Clark J A M Zeebregts; Steven M van Sterkenburg; Robert H Geelkerken; Andre M van Rij; Michael J A Williams; Albert P M Boll; Jelena P Kostic; Adalbjorg Jonasdottir; Aslaug Jonasdottir; G Bragi Walters; Gisli Masson; Patrick Sulem; Jona Saemundsdottir; Magali Mouy; Kristinn P Magnusson; Gerard Tromp; James R Elmore; Natzi Sakalihasan; Raymond Limet; Jean-Olivier Defraigne; Robert E Ferrell; Antti Ronkainen; Ynte M Ruigrok; Cisca Wijmenga; Diederick E Grobbee; Svati H Shah; Christopher B Granger; Arshed A Quyyumi; Viola Vaccarino; Riyaz S Patel; A Maziar Zafari; Allan I Levey; Harland Austin; Domenico Girelli; Pier Franco Pignatti; Oliviero Olivieri; Nicola Martinelli; Giovanni Malerba; Elisabetta Trabetti; Lewis C Becker; Diane M Becker; Muredach P Reilly; Daniel J Rader; Thomas Mueller; Benjamin Dieplinger; Meinhard Haltmayer; Sigitas Urbonavicius; Bengt Lindblad; Anders Gottsäter; Eleonora Gaetani; Roberto Pola; Philip Wells; Marc Rodger; Melissa Forgie; Nicole Langlois; Javier Corral; Vicente Vicente; Jordi Fontcuberta; Francisco España; Niels Grarup; Torben Jørgensen; Daniel R Witte; Torben Hansen; Oluf Pedersen; Katja K Aben; Jacqueline de Graaf; Suzanne Holewijn; Lasse Folkersen; Anders Franco-Cereceda; Per Eriksson; David A Collier; Hreinn Stefansson; Valgerdur Steinthorsdottir; Thorunn Rafnar; Einar M Valdimarsson; Hulda B Magnadottir; Sigurlaug Sveinbjornsdottir; Isleifur Olafsson; Magnus Karl Magnusson; Robert Palmason; Vilhelmina Haraldsdottir; Karl Andersen; Pall T Onundarson; Gudmundur Thorgeirsson; Lambertus A Kiemeney; Janet T Powell; David J Carey; Helena Kuivaniemi; Jes S Lindholt; Gregory T Jones; Augustine Kong; Jan D Blankensteijn; Stefan E Matthiasson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2010-07-11       Impact factor: 38.330

5.  ABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial disease.

Authors:  Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingheti; Danyelle Romana Alves Rios; Luci Maria SantAna Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

6.  Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study.

Authors:  Taeyeon Lee; Na Lu; David T Felson; Hyon K Choi; Deepan S Dalal; Yuqing Zhang; Maureen Dubreuil
Journal:  Rheumatology (Oxford)       Date:  2016-03-15       Impact factor: 7.580

7.  Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.

Authors:  L M Steffen; M Cushman; J M Peacock; S R Heckbert; D R Jacobs; W D Rosamond; A R Folsom
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

Review 8.  Platelet receptors and signaling in the dynamics of thrombus formation.

Authors:  José Rivera; María Luisa Lozano; Leyre Navarro-Núñez; Vicente Vicente
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

9.  Direct oral anticoagulant treatment of deep vein thrombosis reduces IL-6 expression in peripheral mono-nuclear blood cells.

Authors:  Saverio Candido; Giovanni Lumera; Giuliana Barcellona; Davide Vetri; Elda Tumino; Ingrid Platania; Evelise Frazzetto; Graziella Privitera; Carmela Incognito; Agostino Gaudio; Salvatore Santo Signorelli
Journal:  Exp Ther Med       Date:  2020-10-21       Impact factor: 2.447

Review 10.  Oral anticoagulants in the management of venous thromboembolism.

Authors:  John N Makaryus; Jonathan L Halperin; Joe F Lau
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.